View Older Stories View More Recent Stories

Nov 4, 2015 06:43AM MeetMe (MEET) PT Bumped to $4.25 at Roth Capital Post Q3
Nov 4, 2015 06:40AM Roth Capital Downgrades Enphase Energy (ENPH) to Neutral
Nov 3, 2015 11:49AM Roth Affirms Rexahn Pharma (RNN) at 'Buy'; Broad POC Program Initiation, Archexin Data in mRCC on Tap
Nov 3, 2015 09:26AM VBL Therapeutics (VBLT) Prices $15M Offering of Ordinary Shares and Warrants
Nov 3, 2015 09:21AM Vascular Biogenics Ltd. Announces Pricing of $15 Million Underwritten Offering of Ordinary Shares and Warrants
Nov 3, 2015 09:21AM Vascular Biogenics Ltd. Announces Pricing of $15 Million Underwritten Offering of Ordinary Shares and Warrants
Nov 3, 2015 07:09AM Roth Capital Cuts Price Target on Constant Contact (CTCT) Following Announced Acquisition by Endurance International Group (EIGI)
Nov 2, 2015 03:25PM Notable 52-Week Highs and Lows 11/2:(MGM) (GT) (NEO) High; (EIGI) (TKAI) (ENPH) Low
Nov 2, 2015 08:20AM Roth Capital Expects In-Line Results From SolarEdge Technologies (SEDG) 1Q16
Nov 2, 2015 08:01AM Roth Capital Cuts Price Target on Enphase Energy (ENPH) Ahead of 3Q Earnings Report
Nov 2, 2015 07:52AM Escalade (ESCA) Reports 3Q EPS Miss; Roth Capital Reiterates Buy
Oct 30, 2015 08:32AM Exact Sciences (EXAS) Releases Light 4Q Guidance; Roth Capital Cuts Price Target to $12
Oct 30, 2015 08:08AM SolarCity's (SCTY) Kitchen Sink Quarter – Roth Capital
Oct 29, 2015 12:59PM Roth Capital Upgrades GP Strategies (GPX) to Buy
Oct 29, 2015 11:47AM OCTANe Set to Host 10th Annual Medical Device & Investor Forum
Oct 29, 2015 11:17AM Notable Analyst Rating Changes 10/29: (LNCE) (MPEL) (PEGI) Upgraded; (RL) (DG) (ROK) Downgraded
Oct 29, 2015 09:04AM Roth Capital Reiterates Buy on Ellie Mae (ELLI) Following 3Q Results
Oct 29, 2015 06:49AM Roth Capital Assumes Sucampo Pharmaceuticals (SCMP) at Buy
Oct 28, 2015 10:59AM Notable Analyst Rating Changes 10/28: (TWTR) (AAPL) (MAS) Upgraded; (FIVE) (MRVL) (SBLK) Downgraded
Oct 28, 2015 10:56AM Roth Capital Raises Price Target to $237 on Ultimate Software Group (ULTI) Following 3Q
Oct 28, 2015 09:31AM Pre-Open Stock Movers 10/28: (CMI) (HOT) (CAB) (AIG) (AAPL) Higher; (MCUR) (AKAM) (ICPT) Lower (more...)
Oct 28, 2015 08:53AM Roth Capital Expects Foreign Currency Exchange Rates to Negatively Hit SodaStream's (SODA) 3Q Results
Oct 28, 2015 07:37AM Roth Capital Starts Yelp (YELP) at Sell
Oct 28, 2015 07:31AM Roth Capital Starts MeetMe (MEET) at Buy
Oct 28, 2015 07:17AM China Yida Holding (CNYD) Forms Special Committee to Evaluate Takeover Offer
Oct 27, 2015 02:52PM Roth Capital Maintains Cytokinetics (CYTJK) at 'Buy' Amid Encouraging COSMIC-HF Data
Oct 27, 2015 10:39AM Adesto Technologies (IOTS) IPO Opens Higher
Oct 27, 2015 09:37AM Adesto Technologies (IOTS) Prices 5M Common Stock IPO at $5/Share
Oct 27, 2015 09:29AM Harris & Harris Group Portfolio Company Adesto Raises $25 Million in Initial Public Offering
Oct 26, 2015 06:57PM Adesto Technologies Corporation Prices Initial Public Offering
Oct 26, 2015 06:57PM Adesto Technologies Corporation Prices Initial Public Offering
Oct 26, 2015 08:27AM SolarCity (SCTY) to Report 3Q Earnings on 10/29; Roth Capital Cuts Price Target to $70
Oct 23, 2015 04:31PM Spark Therapeutics to Participate in Four Conferences in October and November
Oct 23, 2015 10:09AM Ligand Pharma (LGND) Announces FDA CRL for Evomela's NDA; Roth Capital Reiterates Buy
Oct 23, 2015 09:24AM NovaBay Pharma (NBY) Prices 12.3M Common Stock, Warrants Offering
Oct 23, 2015 09:23AM NovaBay Announces Pricing of Public Offering of Common Stock and Warrants
Oct 23, 2015 09:18AM Roth Capital Trims PT on Ligand (LGND) to $138; Will Remove Evomela from Revenue Projections (SPPI)
Oct 22, 2015 04:27PM NovaBay Pharma (NBY) Announces Common Stock, Warrants Offering
Oct 22, 2015 04:26PM NovaBay Announces Proposed Public Offering of Common Stock and Warrants
Oct 22, 2015 08:20AM Roth Capital Raises Price Target Following Natus Medical's (BABY) 3Q Results
Oct 21, 2015 04:05PM Strongbridge Biopharma plc Announces Closing of Initial U.S. Public Offering
Oct 21, 2015 08:41AM Roth Capital Downgrades Synta Pharma. (SNTA) to Neutral; $1 PT
Oct 19, 2015 04:15PM Hannon Armstrong Sustainable Infrastructure Capital, Inc. Announces the Closing of its Public Offering of Common Stock
Oct 19, 2015 01:59PM bluebird bio (BLUE) Stock Reaction Has No Correlation with Current Data/Program, Roth Capital Says
Oct 19, 2015 09:08AM Roth Capital Reiterates Buy on Ideal Power (IPWR) Following ESNA Trade Show
Oct 19, 2015 09:06AM Roth Capital Positive on Curis' (CRIS) Move into Immuno-Oncology Field; Reaffirms at 'Buy'
Oct 19, 2015 08:53AM Roth Capital Cuts Price Target on Cempra (CEMP) as Solithromycin Misses High Expectations
Oct 19, 2015 07:51AM Roth Capital Cits Price target After Synergy Resources (SYRG) Reports 6c EPS Miss
Oct 16, 2015 11:51AM Roth Remains on Sidelines with PTC Therapeutics (PTCT) Until More Clarity is Observed; Affirms at 'Neutral'
Oct 16, 2015 10:28AM Strongbridge Biopharma (SBBP) IPO Opens Up 30%
View More Recent Stories View Older Stories